Current and Emerging Drugs in the Treatment of Anemia in Patients with Chronic Kidney Disease
Anemia is a common complication of chronic kidney disease (CKD), and its prevalence has shown a tendency to increase in many countries. Anemia is associated with incident heart failure and increases mortality in CKD patients, garnering public attention. Here, we reviewed recent studies about CKD wi...
Main Authors: | Hongzhen Zhong, Wenshan Lin, Tianbiao Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Canadian Society for Pharmaceutical Sciences
2020-08-01
|
Series: | Journal of Pharmacy & Pharmaceutical Sciences |
Online Access: | https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/30919 |
Similar Items
-
The role of hypoxia-inducible factor stabilizers in the treatment of anemia in patients with chronic kidney disease
by: Zhong H, et al.
Published: (2018-09-01) -
The Efficacy of Mesenchymal Stem Cells in Therapy of Acute Kidney Injury Induced by Ischemia-Reperfusion in Animal Models
by: Tianbiao Zhou, et al.
Published: (2020-01-01) -
Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents
by: Jose Portolés, et al.
Published: (2021-03-01) -
Current and emerging treatment options for the elderly patient with chronic kidney disease
by: Fassett RG
Published: (2014-01-01) -
Intravenous Iron Drugs Usage in the Treatment of Iron Deficiency Anemia in Patients with Chronic Kidney Disease
by: D.D. Ivanov, et al.
Published: (2016-08-01)